Healthy Skepticism Library item: 11881

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Campbell EG.
Doctors and Drug Companies — Scrutinizing Influential Relationships
NEJM 2007 Nov 1; 357:(18):1796-1797
http://content.nejm.org/cgi/content/full/357/18/1796

Abstract:

On September 6, 2007, Senators Charles Grassley (R-IA), the ranking member of the Committee on Finance, and Herb Kohl (D-WI), chairman of the Special Committee on Aging, introduced the Physician Payments Sunshine Act – so named because it aims to “shine a much needed ray of sunlight on a situation that contributes to the exorbitant cost of health care,” according to cosponsor Senator Charles Schumer (D-NY). The bill would require manufacturers of pharmaceuticals and medical devices with annual revenues of more than $100 million to disclose the amount of money they give to physicians – whether in the form of . . .

Notes:

Free full text